|
ND-Issue-6-2003
SOFTWARE SOLUTIONS
FOR DRUG Discovery

LION Bioscience recently announced a realignment in the company’s business model and adjustments to the product and service programme. NewDrugs talked to Dr. Werner Eberhardt, Vice President Global Marketing, on company strategy and perspectives.
|
|
|
| Dr Werner Eberhardt, Vice President Global Marketing, Lion Bioscience |
|